trending Market Intelligence /marketintelligence/en/news-insights/trending/ya6qg4peptv8flh8jgpcwg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

UniQure appoints 2 board members

Blog

Banking Essentials Newsletter - February Edition

Blog

Message in a (Word)Cloud

Six trends shaping the industries and sectors we cover in 2021

Six trends shaping the industries and sectors we cover in 2021


UniQure appoints 2 board members

Amsterdam-based gene therapy company uniQure NV appointed Robert Gut and David Meek to the board.

Gut is currently the chief medical officer for Versartis Inc. Meek has been the CEO of Ipsen SA since 2016.